Home > Insider Trading > Filing (0001415889-22-000480)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1750284	Olema Pharmaceuticals Inc.	OLMA	Pharmaceutical Preparations (2834)	300409740

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1831215	Kinney Horn	C/O Olema Pharmaceuticals, Inc. 512 2Nd Street, 4Th Floor San Francisco CA 94107	Chief Business Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-01-10	5,251	$2.06	7,709	No	4	M	Direct
Common Stock	Disposition	2022-01-10	5,251	$6.85	2,458	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2022-01-10	5,251	$0.00	5,251	$2.06

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
152,289		2030-06-09	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
The weighted average sale price for the transaction reported was $6.85, and the range of prices were between $6.60 and $7.22. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.